Drug profile · INN
pinacidil
PINDAC
pinacidil (PINDAC) is a sulfonylurea receptor 2, kir6.2 opener. Route of administration: oral. Current US regulatory status: approved.
Drug details — pinacidil
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
pinacidil (PINDAC) is a sulfonylurea receptor 2, kir6.2 opener. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Sulfonylurea receptor 2, Kir6.2 opener
Primary target: Sulfonylurea receptor 2, Kir6.2
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is pinacidil?
pinacidil (PINDAC) is a sulfonylurea receptor 2, kir6.2 opener. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for pinacidil?
PINDAC is a marketed brand name for pinacidil. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pinacidil?
pinacidil has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.